News items related to: News
-
ICASA 2017: Optimal HIV treatment for ALL
As the 2017 International Conference on AIDS and STIs in Africa (ICASA) draws to a close in Abidja, Cote d’Ivoire,...
-
Argentina: Patent rejected on hepatitis C drug, sofosbuvir
A decision by the patent office in Argentina (INPI) to reject Gilead’s patent on key hepatitis C drug, sofosbuvir, is...
-
“Southern Africa must be innovative to tackle access to HIV and TB treatment” says ARASA
The right to life is being denied due to high prices for medicines. Addressing pharmaceuticals’ abuse of intellectual property law...
-
World AIDS Day 2017: Argentina remains without an effective HIV and hepatitis law
It’s perceived, that due to the lack of political will of the national government and a lack of interest from...
-
‘Questionable’ patent on key HIV drug is challenged in Brazil
Legal challenge essential to prevent further barriers to optimal HIV treatment in Brazil. ABIA, our campaign partner in Brazil, is...
-
Let’s talk about it! Thai partner broadcasts on Facebook Live for World AIDS Day
Discussing the issues and facts head-on in order to reduce HIV-related stigma in Thailand. Story first published on The Nation,...
-
São Paulo protest exposes how Gilead’s actions block access to medicines around the world
In São Paulo, on 31 October 2017, activists from around the world held a protest at the headquarters of...
-
New Study: Assessment of national intellectual property landscapes and their impact on access to medicines (Egypt, Morocco, Tunisia)
ITPC-MENA has released a comparative study of intellectual property provisions in Tunisia, Morocco and Egypt. The study was undertaken to...
-
HIV activists trained on intellectual property and access to medicines
Demystifying intellectual property (IP) and providing advocacy tools. The International Treatment Preparedness Coalition – MENA (ITPC-MENA) with the support...
-
The Indonesian patent club – and its impact on Hep C treatment
Communities are refusing to accept patent abuse – challenging unmerited patents, and finding ways around them in the meantime. Community...
-
Myanmar: Creating an intellectual property law that protects public health
Lobbying for an intellectual property law that doesn’t just serve big business, but protects public health and encourages innovation in...
-
The Network vs. Abbvie – the first victory in reducing cost of HIV drug
The first victory has been won – and our partner in Ukraine intends to see the case through. On 4...